Who owns Axsome Therapeutics, Inc. (AXSM)? Elite investor 13F holders
7 tracked elite investors reported holding Axsome Therapeutics, Inc as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Bridgewater Associates, Tudor Investment, Torray Funds. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 148025392.00 USD | 604753.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 64129740.00 USD | 262000.000000 | Shares | add | Original filing |
| Bridgewater Associates | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14249775.00 USD | 58217.000000 | Shares | add | Original filing |
| Tudor Investment | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4638392.00 USD | 18950.000000 | Shares | buy | Original filing |
| Torray Funds | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 3653927.00 USD | 14928.000000 | Shares | add | Original filing |
| Polen Capital Management | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 1093632.00 USD | 4468.000000 | Shares | add | Original filing |
| Gotham Asset Management | AXSOME THERAPEUTICS INC. | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 239875.00 USD | 980.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.